Title 16 Health & Social Services
4100 Family Health Services
4101 Birth Defect Surveillance and Registry Program
1.0 Purpose
1.1 Birth defects are one of the causes of infant mortality and disabilities in Delaware. A Birth Defects Surveillance System, or Birth Defects Registry, will enable the Department of Health and Social Services (DHSS), Division of Public Health (DPH) to collect birth defects data, to create a statewide registry, and to link surveillance with tracking of individual children for the provision of services.
1.2 The purpose of the Birth Defects Registry is to provide information to Public Health officials as to the existence of previously unrecognized health and environmental hazards, help prevent certain birth defects and ultimately decrease the infant mortality rate. The Birth Defects Registry will gather data to assist with identification of risk factors, including environmental and hereditary, assist in the investigation of causes and prevalence; assist in the development of strategies to reduce the occurrence of, or prevent such defects; and track and follow-up abnormal newborn hearing screening results.
1.3 The usefulness of the data collected in the Birth Defects Registry will depend upon the full and accurate reporting of such defects by health care practitioners, health care facilities, clinics and laboratories.
1.4 The Birth Defects Registry will be a component of the Newborn Screening Case Management System, including metabolic and hearing screening. All results of metabolic and hearing screens will become part of the screening record. Tracking and follow-up of incomplete and abnormal cases will be followed by the Division of Public Health Newborn Screening Program.
2.0 Definitions
The following words shall have the meanings indicated:
"Birth Defect" means any structural or biochemical abnormality, regardless of cause, diagnosed at any time before or after birth, that requires medical or surgical intervention or that interferes with normal growth or development. This includes abnormal newborn hearing screening. Reportable birth defects are listed in Appendix A of these Regulations.
"Division" refers to the Division of Public Health under the Department of Health and Social Services.
"Registry" means a central data bank containing collected, classified, coded, and sorted data relating to defects in children under age 5, reported by health care providers.
"Surveillance" means the process of identifying and investigating birth defects in children under age 5.
3.0 Reporting Requirements
The provisions of this section shall apply to the Delaware Health and Social Services, Division of Public Health, Birth Defect Registry:
3.1 The registry shall collect information on any birth defect diagnosed in utero and postpartum on anyone who is a resident of the state of Delaware, or whose parent is a resident of Delaware, and who is diagnosed at any time prior to age five (5) as having a birth defect. For the purposes related to the registry the Division shall have access to any medical record of the child that pertains to a diagnosed or suspected birth defect. Prenatal information on the birth mother may be obtained with prior consent.
3.2 Any diagnosed birth defects shall be reported for all infants and children up to age 5, including those who have since died (if the data is still available).
3.3 For purposes of these reporting requirements, reportable diagnoses are those diagnoses, from the International Classification of Diseases (ICD), as listed in Appendix A of these regulations. The reportable diagnoses listed in Appendix A may be revised, upon notice, to reflect changes in publications accepted for use by the Centers for Disease Control and Prevention or State.
3.4 The following persons and organizations are required to report occurrences of birth defects within 30 days of diagnosis to the Division of Public Health.
3.4.1 Any physician, surgeon, dentist, podiatrist, certified nurse midwife, or other health care practitioner who diagnoses or provides treatment, or both, for a child under age 5 with birth defects who is not known to be previously reported;
3.4.2 The designated representative of any clinical laboratory that performs any test which identifies a child or children under age 5 with birth defects not known to be previously reported; and
3.4.3 The designated representative of any hospital, dispensary, clinic, or other similar public or private institution that diagnoses or provides treatment, or both, for a child or children under age 5 with birth defects who is not known to be previously reported.
3.4.4 This section of the regulations shall not apply to any person or private institution that, as an exercise of religious freedom, treats the sick or suffering by spiritual means through prayer alone.
3.5 The administrative officer of every health care facility shall be responsible for establishing reporting procedures at that facility, using the identified Birth Defect Registry reporting form. Reporting procedures must ensure that each infant initially diagnosed as having a birth defect shall be reported to the Division. Any presumptive or actual diagnosis in a child up to the age of 5 must be reported to the Division.
3.6 Reporting sources shall complete the Division of Public Health Birth Defects Surveillance Form for each reported case, and forward the completed form to the Division of Public Health Director or designee.
3.7 Reporting sources are required to submit annual follow-up information as requested through Birth Defect Program.
4.0 Confidentiality of Reports
4.1 No report of a diagnosis or treatment of a birth defect shall be disclosed in such a way as to identify the child who is the subject of the report, or as to identify the child's family. However, patient-identifying information may be exchanged among authorized agencies as approved by the Department and upon receipt by the Department of satisfactory assurances by those agencies of the preservation of the confidentiality of such information. Agencies will maintain the confidentiality of any information exchanged for the purpose of delivery of program services, evaluation, early intervention and epidemiological investigation.
4.2 Any parent, custodian or guardian of any infant having any birth defect may refuse disclosure to the surveillance system and registry of the infant’s name and identifying information on the grounds that such birth defect identification is contrary to the religious tenets and practices of the infant’s parent, custodian or guardian.
4.3 No individual or organization providing information pursuant to these regulations shall be held liable for divulging such information to the Division.
5.0 Penalties
Any person or organization required to report the diagnosis or treatment of a birth defect pursuant to these regulations, and who violates these regulations, shall be subject to a fine of up to $100 for each violation, pursuant to 16 Del.C. Sec. 206. Justices of the Peace Courts have jurisdiction over such violations.
6.0 Severability
In the event any particular clause or section of the regulations should be declared invalid or unconstitutional by any court of competent jurisdiction, the remaining portions shall remain in full force and effective.
Table 1: APPENDIX A October 2002
DELAWARE BIRTH DEFECTS REGISTRY REPORTABLE DIAGNOSES | ||
Broad Categories |
Specific Categories |
ICD-9 Codes |
Congenital Infections |
||
Congenital syphilis |
090.0 - 090.3 | |
Congenital rubella |
771.0 | |
Congenital cytomegalovirus |
771.1 | |
Congenital toxoplasmosis (not specific code) |
771.2 | |
Other infections specific to perinatal period |
771.80 | |
Other congenital infections |
771.x | |
Neoplasms |
Neurofibromatosis |
237.70 |
Endocrine, Nutritional, Metabolic, Immunological Diseases |
||
Congenital hypothyroidism |
243.00 | |
Phenylketonuria |
270.10 | |
Galactosemia |
271.1 | |
Cystic Fibrosis |
277.00.01 | |
Other Metabolic diseases |
||
Diseases of Blood |
||
Sickle Cell Disease |
282.60 | |
Other hemoglobinopathies |
282.63, 282.69, 282.4 | |
Developmental Disorders |
||
Developmental Language Disorder |
315.31-315.39 | |
Coordination Disorder |
315.40 | |
Mental Retardation |
317 - 319 | |
Congenital Anomalies of Central Nervous System |
||
Anencephalus |
740.0 -740.1 | |
Spina bifida without anencephalus |
741.0,741.9 w/o 740.0-740.10 | |
Hydrocephalus without spina bifida |
742.3 w/o 741.0, 741.9 | |
Encephalocele |
742.0 | |
Microcephalus |
742.1 | |
Holoprosencephaly/Porencephaly |
742.2 | |
Other Congenital Anomalies of Nervous System |
742.4 - 742.9 | |
Congenital Anomalies of the Eye |
||
Anophthalmia/microphthalmia |
743.0,743.1 | |
Congenital cataract |
743.30 -743.34 | |
Aniridia |
743.45 | |
Glaucoma |
743.20 -743.22 | |
Coloboma |
743.46* | |
Congenital Anomalies of the Ear |
||
Anotia/microtia |
744.01,744.23 | |
Congenital Anomalies of the Cardiovascular System |
||
Common truncus |
745.0 | |
Transposition of great arteries |
745.10,745.11, 745.12, 745.19 | |
Tetralogy of Fallot |
745.2 | |
Ventricular septal defect |
745.4 | |
Atrial Septal Defect |
745.5 | |
Endocardial cushion defect |
745.60,745.61, 745.69 | |
Single Ventricle |
745.3 | |
Pulmonary valve atresia and stenosis |
746.01,746.02 | |
Tricuspid valve atresia and stenosis |
746.1 | |
Ebstein’s anomaly |
746.2 | |
Aortic valve stenosis |
746.3 | |
Hypoplastic left heart syndrome |
746.7 | |
Patent ductus arteriosus >2500 gms |
747.0 | |
Coarctation of aorta |
747.10 | |
Pulmonary artery anomalies |
747.3 | |
Congenital anomalies of the Respiratory System |
||
Anomalies of larynx/trachea/bronchus |
748.30 | |
Lung agenesis/hypoplasia |
748.5 | |
Other respiratory anomalies |
||
Congenital Anomalies of the Orofacial Area |
||
Cleft palate without cleft lip |
749.00 -749.04 | |
Cleft lip with or without cleft palate |
749.1,749.2 | |
Choanal atresia |
748.0 | |
Congenital Anomalies of the Gastrointestinal Tract |
||
Esophageal atresia/tracheoesophageal fistula |
750.3 | |
Atresia/stenosis of intestine and rectum |
751.10,751.2 | |
Hirschsprung’s disease (congenital megacolon) |
751.3 | |
Anomalies of internal fixation of bowel |
751.40 | |
Biliary atresia |
751.61 | |
Malrotation of intestine |
751.4* | |
Pyloric stenosis |
750.5 | |
Anorectal malformation |
751.4* | |
Congenital Anomalies of the Genitourinary System |
||
Renal Agenesis/hypoplasia |
753.0 | |
Bladder exstrophy |
753.5 | |
Cloacal exstrophy |
* | |
Cystic/dysplastic kidneys |
753.10,753.15 | |
Obstructive genitourinary defect |
753.2,753.6 | |
Hypospadias and Epispadias |
752.6 | |
Ambiguous genitalia |
752.9* | |
Polycystic kidneys |
753.12 -753.14 | |
Congenital Anomalies of the Musculoskeletal Regions |
||
Reduction defect, upper limbs |
755.20 -755.29 | |
Polydactyly/ Syndactyly/ Adactyly |
755.00 -755.02 755.10 -755.14 755.4* | |
Reduction defect, lower limbs |
755.30-755.39 | |
Arthrogryposis multiplex congenital |
754.89* | |
Achondroplasia |
756.4 | |
Osteogenesis imperfecta |
756.51 | |
Other skeletal dysplasia Gastroschisis |
756.7 | |
Omphalocele |
756.7 | |
Diaphragmatic hernia (moved up) |
756.6 | |
Scoliosis/Lordosis/Kyphosis |
754.0, 756.19 | |
Congenital hip dysplasia |
754.30, 754.31 | |
754.35* | ||
Club Foot |
754.50, 51, 53, 60, 70, 79 | |
Craniosynostosis |
756.0* | |
Chromosomal Disorders |
||
Trisomy 21 (Down syndrome) |
758.0 | |
Trisomy 13 |
758.1 | |
Trisomy 18 |
758.2 | |
Autosomal deletion syndromes |
758.30 | |
Other conditions due to autosomal anomalies |
758.50 | |
Gonadal dysgenesis (Turner’s syndrome) |
758.60 | |
Klinefelter’s syndrome |
758.70 | |
Other conditions due to sex chromosome anomalies |
758.80 | |
Conditions due to anomaly of unspecified Chromosome |
758.90 | |
Fragile X Syndrome |
759.83 | |
Other Congenital Malformations |
||
Amniotic bank disruption complex |
no code | |
Embryopathy from Toxic Exposure in Utero |
||
Fetal Alcohol syndrome |
760.71 | |
Phenytoin |
760.79* | |
Isotretinoin |
760.79* | |
Warfarin |
760.79* | |
Other toxic exposures |
760.7x | |
Conductive hearing loss, external ear |
389.01 | |
Conductive hearing loss, middle ear |
389.03 | |
Ear disorder, unspecified |
388.9 | |
Hearing loss, noise-induced |
388.12 | |
Hearing loss, sudden, unspecified |
388.2 | |
Hearing loss, unspecified |
388.9 | |
Sensorineural hearing loss, unspecified |
389.10 | |
Please note: The DHSS regulations on this website are not as yet complete. In conjunction with the Delaware Registrar of Regulations, DHSS is in process of compiling regulations relating to Title 16, as part of the continuing project to develop the Delaware Administrative Code.

